Impact of renal aging on drug therapy

References

• Waltman K WS. Preventing adverse drug reactions. Philadelphia: Hanley & Belfus; 2000
   Google Scholar
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345–51
   PubMedGoogle Scholar
• Weiss BD, Lee JK. Aging: Is your patient taking too many pills? J Fam Pract 2012;61:652–61
   PubMed Web of Science ®Google Scholar
• Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78:1564–77
   PubMed Web of Science ®Google Scholar
• Willlams CM. Using medications appropriately in older adults. Am Fam Physician 2002;66:1917–24
   PubMed Web of Science ®Google Scholar
• Musso CG. Geriatric nephrology and the “nephrogeriatric giants”. Int Urol Nephrol 2002;34:255–6
   PubMedGoogle Scholar
• Musso CG. Acute renal failure in the elderly: pearls for its assessment and treatment. Electron J Biomed 2005;1:1–93
   Google Scholar
• Renkke H, Denker B. Renal pathophysiology. Philadelphia: Lippincott Williams & Wilkins; 2007
   Google Scholar
• Onuigbo MA, Onuigbo NT. The syndrome of rapid onset end-stage renal disease (SOROESRD) – A new mayo clinic dialysis services experience, January 2010-February 2011. In Di Iorio B, Heidland A, Onuigbo M, Ronco C, Editors. Hemodialysis: When, How, Why. New York, NY: NOVA Publishers; 2012; p 443–85
   Google Scholar
• Onuigbo M, Onuigbo N, Musso CG. Syndrome of rapid-onset end-stage renal disease in incident Mayo Clinic chronic hemodialysis patients. Indian J Nephrol 2014;24:75–81
   PubMedGoogle Scholar
• Musso CG, Jauregui J. Renin-angiotensin-aldosterone system and the aging kidney. Endocrinol Metab 2014;9:1–4
   Google Scholar
• Musso CG, Oreopoulos D. Renal changes in the elderly. In Katlic M, Editor. Cardiothoracic surgery in the elderly. Evidence-based practice. New York: Springer; 2011
   Google Scholar
• Musso CG, Macias Nunez JF, Oreopoulos DG. Physiological similarities and differences between renal aging and chronic renal disease. J Nephrol 2007;20:586–7
   PubMed Web of Science ®Google Scholar
• Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 2011;119:(Suppl 1):1–5
   Google Scholar
• Hojs R, Bevc S, Antolinc B, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in the elderly. Int J Clin Pharmacol Res 2004;24:49–54
   PubMedGoogle Scholar
• Törner A, Odar-Cederlöf I, Kallner A, Akner G. Renal function in community-dwelling frail elderly. Comparison between measured and predicted glomerular filtration rate in the elderly and proposal for a new cystatin C-based prediction equation. Aging Clin Exp Res 2008;20:216–25
   PubMed Web of Science ®Google Scholar
• Wei L, Ye X, Pei X, Wu J, Zhao W. Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly. PLoS One 2014;9:e86066
   Google Scholar
• Keller F. Kidney function and age. Nephrol Dial Transplant 1987;2:382
   PubMedGoogle Scholar
• Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007;72:632–7
   PubMed Web of Science ®Google Scholar
• Aymanns C, Keller F, Maus S, Hartmann B, Czock D. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clin J Am Soc Nephrol 2010;5:314–27
   PubMed Web of Science ®Google Scholar
• Musso CG, Oreopoulos D. Geriatric nephrology. In Pathy J, Sinclair A, Morley J, Editors. Principles and practice of geriatric medicine. West Sussex: Wiley; 2012
   Google Scholar
• Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, Kuhlmann MK, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012;157:471–8
   PubMed Web of Science ®Google Scholar
• Alshaer IM, Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP, et al. External validation of the Berlin equations for estimation of GFR in the elderly. Am J Kidney Dis 2014;63:862–5
   PubMed Web of Science ®Google Scholar
• Denneboom W, Dautzenberg MG, Grol R, De Smet PA. Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 2006;56:504–10
   PubMed Web of Science ®Google Scholar
• Manitpisitkul P, Curtin CR, Shalayda K, Wang SS, Ford L, Heald DL. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis or hepatic impairment. Epilepsy Res 2014;108:891–901
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine and topiramate: a comparison of the impact of age and comedication. Ther Drug Monit 2012;34:440–5
   PubMed Web of Science ®Google Scholar
• Lal R, Sukbuntherng J, Luo W, Chen D, Blumenthal R, Ho J, Cundy KC. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Clin Ther 2012;34:201–13
   PubMed Web of Science ®Google Scholar
• Sultana J, Spina E, Trifirò G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opin Drug Metab Toxicol 2015;3:1–10
   Google Scholar
• Scibona P, Angriman F, Vazquez C, Ferreyro BL, Perelsztein AG, Simonovich VA, Jauregui JR, et al. Individualisation of drug therapy in older people. Rev Clin Gerontol 2014;24:145–57
   Google Scholar
• Musso CG, Michelángelo H, Vilas M, Reynaldi J, Martinez B, Algranati L, Macías Núñez JF. Creatinine reabsorption by the aged kidney. Int Urol Nephrol 2009;41:727–31
   PubMed Web of Science ®Google Scholar
• Musso CG, Ghezzi L, Ferraris J. Renal physiology in newborns and old people: similar characteristics but different mechanisms. Int Urol Nephrol 2004;36:273–6
   PubMed Web of Science ®Google Scholar
• Musso CG, Macías-Núñez JF. Dysfunction of the thick loop of Henle and senescence: from molecular biology to clinical geriatrics. Int Urol Nephrol 2011;43:249–52
   PubMed Web of Science ®Google Scholar
• Musso CG, Miguel Rd, Algranati L, Farias Edos R. Renal potassium excretion: comparison between chronic renal disease patients and old people. Int Urol Nephrol 2005;37:167–70
   PubMedGoogle Scholar
• Musso C, Liakopoulos De Miguel R, Imperiali N, Algranati L. Transtubular potassium concentration gradient: comparison between healthy old people and chronic renal failure patients. Int Urol Nephrol 2006;38:387–90
   PubMed Web of Science ®Google Scholar
• Lacy C, Armstrong L, Goldman M, Lance L. Drug Information Handbook. Philadelphia: Lexi-Comp; 2004. p 646–8
   Google Scholar
• Musso CG, Juarez R, Vilas M, Navarro M, Rivera H, Jauregui R. Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III- chronic kidney disease and healthy oldest old. Int Urol Nephrol 2012;44:1559–62
   PubMed Web of Science ®Google Scholar
• Musso CG, Alvarez Gregory J, Macías Núñez JF. Renal handling of uric acid, magnesium, phosphorus, calcium, and acid base in the elderly. In Núñez M, Cameron S, Oreopoulos D, Editors. Renal ageing: health and disease. New York: Springer; 2008. p 155–71
   Google Scholar
• Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol 2009;41:357–62
   PubMed Web of Science ®Google Scholar
• Musso CG, Reynaldi J, Vilas M, De Miguel R, Imperiali N, Algranati L. Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people. Int Urol Nephrol 2010;42:273–7
   PubMed Web of Science ®Google Scholar
• Musso CG, Macías Núñez JF. Renal handling of water and electrolytes in the old and old-old healthy aged. In Núñez M, Cameron S, Oreopoulos D, Editors. Renal ageing: health and disease. New York: Springer; 2008. p 141–54
   Google Scholar
• Fulop TJr, Worum I, Csongor J, Foris G, Leovey A. Body composition in elderly people. I. Determination of body composition by multiisotope method and the elimination kinetics of these isotopes in healthy elderly subjects. Gerontology 1985;31:6–14
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Hattis D, Russ A, Sonawane B. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ Health Perspect 2005;113:1243–9
   PubMed Web of Science ®Google Scholar
• McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163–84
   PubMed Web of Science ®Google Scholar
• Perucca E. Age-related changes in pharmacokinetics: predictability and assessment methods. Int Rev Neurobiol 2007;81:183–99
   PubMed Web of Science ®Google Scholar
• Noreddin AM, Haynes V. Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly. Drugs Aging 2007;24:275–92
   PubMed Web of Science ®Google Scholar
• Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet 2008;47:297–321
   PubMed Web of Science ®Google Scholar
• Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185–91
   PubMed Web of Science ®Google Scholar
• Yoo SH, Kwon SU, Jo MW, Kang DW, Kim JS. Age and weight adjusted warfarin initiation nomogram for ischaemic stroke patients. Eur J Neurol 2012;19:1547–53
   PubMed Web of Science ®Google Scholar
• Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon M, et al. Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 2010;56:823–31
   PubMed Web of Science ®Google Scholar
• Frishman WH, Aronow WS. Pharmacology of antiarrhythmic drugs in elderly patients. Clin Geriatr Med 2012;28:575–615
   PubMedGoogle Scholar
• Wang L. Changes in pharmacokinetics in the elderly and therapeutic drug monitoring of antiarrhythmic drugs. Life Sci J 2007;4:1–7
   Google Scholar
• Dettli L. Drug dosage in renal disease. Clin Pharmacokinet 1976;1:126–34
   PubMedGoogle Scholar
• Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev 2006;58:521–90
   PubMed Web of Science ®Google Scholar
• Ruiz JG, Array S, Lowenthal DT. Therapeutic Drug Monitoring in the Elderly. Am J Ther 1996;3:839–60
   PubMedGoogle Scholar
• Ghiculescu R. Therapeutic drug monitoring: which drugs, why, when and how to do it. Aust Prescriber 2008;31:42–4
   Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;41:67–76
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II). Clin Pharmacokinet 1991;21:262–73
   PubMed Web of Science ®Google Scholar
• Lundmark J, Bengtsson F, Nordin C, Reis M, Walinder J. Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatr Scand 2000;101:354–9
   PubMed Web of Science ®Google Scholar
• Bonetti A, Franceschi T, Apostoli P, Cetto GL, Recaldin E, Molino A, et al. Cisplatin pharmacokinetics in elderly patients. Ther Drug Monit 1994;16:477–82
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Abernethy DR, Shader RI. Pharmacokinetic aspects of drug therapy in the elderly. Ther Drug Monit 1986;8:249–55
   PubMed Web of Science ®Google Scholar
• Waade RB, Molden E, Refsum H, Hermann M. Serum Concentrations of Antidepressants in the elderly. Ther Drug Monit 2012;34:25–30
   PubMed Web of Science ®Google Scholar